BE895750A - Nouvelles compositions pharmaceutiques administrables par voie nasale - Google Patents

Nouvelles compositions pharmaceutiques administrables par voie nasale

Info

Publication number
BE895750A
BE895750A BE1/10708A BE1010708A BE895750A BE 895750 A BE895750 A BE 895750A BE 1/10708 A BE1/10708 A BE 1/10708A BE 1010708 A BE1010708 A BE 1010708A BE 895750 A BE895750 A BE 895750A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
new nasal
administrative
administrative pharmaceutical
nasal
Prior art date
Application number
BE1/10708A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE895750A publication Critical patent/BE895750A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE1/10708A 1982-02-01 1983-01-31 Nouvelles compositions pharmaceutiques administrables par voie nasale BE895750A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
BE895750A true BE895750A (fr) 1983-08-01

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10708A BE895750A (fr) 1982-02-01 1983-01-31 Nouvelles compositions pharmaceutiques administrables par voie nasale

Country Status (27)

Country Link
JP (1) JPS58134017A (fr)
AT (1) AT385656B (fr)
AU (1) AU565613B2 (fr)
BE (1) BE895750A (fr)
CA (1) CA1197783A (fr)
CH (1) CH653555A5 (fr)
DE (1) DE3302949A1 (fr)
DK (1) DK164771C (fr)
ES (1) ES8502865A1 (fr)
FI (1) FI81258C (fr)
FR (1) FR2539994B1 (fr)
GR (1) GR81320B (fr)
HK (1) HK59989A (fr)
HU (1) HU191512B (fr)
IE (1) IE54532B1 (fr)
IL (1) IL67822A (fr)
IT (1) IT1197558B (fr)
KE (1) KE3888A (fr)
LU (1) LU84613A1 (fr)
MY (1) MY8700766A (fr)
NL (1) NL192325C (fr)
NZ (1) NZ203117A (fr)
PH (1) PH22198A (fr)
PT (1) PT76166B (fr)
SE (1) SE454402B (fr)
SG (1) SG34389G (fr)
ZA (1) ZA83673B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
RU2020125871A (ru) * 2018-01-05 2022-02-07 Импел Ньюрофарма, Инк. Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
LU84613A1 (fr) 1983-09-08
KE3888A (en) 1989-09-01
SE8300495D0 (sv) 1983-01-31
SE454402B (sv) 1988-05-02
IE830187L (en) 1983-08-01
FI81258C (fi) 1990-10-10
PT76166A (en) 1983-02-01
HU191512B (en) 1987-02-27
JPS58134017A (ja) 1983-08-10
IT1197558B (it) 1988-12-06
NL192325C (nl) 1997-06-04
IL67822A0 (en) 1983-06-15
CA1197783A (fr) 1985-12-10
JPH0253406B2 (fr) 1990-11-16
DE3302949C2 (fr) 1992-05-21
HK59989A (en) 1989-08-04
ES519450A0 (es) 1985-02-01
AT385656B (de) 1988-05-10
AU1085083A (en) 1983-08-11
CH653555A5 (de) 1986-01-15
FR2539994A1 (fr) 1984-08-03
AU565613B2 (en) 1987-09-24
SG34389G (en) 1989-09-22
FR2539994B1 (fr) 1986-10-10
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
NZ203117A (en) 1986-12-05
PH22198A (en) 1988-06-28
IT8347646A0 (it) 1983-02-01
DK164771B (da) 1992-08-17
ES8502865A1 (es) 1985-02-01
NL192325B (nl) 1997-02-03
ATA30383A (de) 1987-10-15
DK38183A (da) 1983-08-02
DK164771C (da) 1992-12-28
MY8700766A (en) 1987-12-31
IL67822A (en) 1988-02-29
FI830245A0 (fi) 1983-01-25
DE3302949A1 (de) 1983-08-11
DK38183D0 (da) 1983-01-31
FI830245L (fi) 1983-08-02
FI81258B (fi) 1990-06-29
IE54532B1 (en) 1989-11-08
SE8300495L (sv) 1983-08-02
GR81320B (fr) 1984-12-11
NL8300325A (nl) 1983-09-01

Similar Documents

Publication Publication Date Title
FI833568A (fi) Nya topiskt applicerbara farmaceutiska kompositioner
BR1100036A (pt) Composto e composição farmacêutica
FI831534L (fi) Oxikam-derivat innehaollande farmaceutiska kompositioner och deras framstaellningsfoerfarande
IT1162879B (it) Composizioni farmaceutiche
IT1214683B (it) Composizioni farmaceutiche nasali
DE3382112D1 (de) Pharmazeutische zusammensetzung.
FR2568773B1 (fr) Nouvelles compositions pharmaceutiques administrables par voie nasale
FI831475L (fi) Nya azepinindoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FR2527078B1 (fr) Compositions pharmaceutiques anti-ulceres
FR2539994B1 (fr) Nouvelles compositions pharmaceutiques administrables par voie nasale
OA06373A (fr) Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.
FI834736A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
BE892709A (fr) Nouvelles compositions pharmaceutiques topiques
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
FI830462L (fi) Mjoeldrygealkaloider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska kompositioner
IT1150694B (it) Composizione farmaceutica ad attivita' immunomodulatrice
IT8221553A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT1152486B (it) Composizione farmaceutica antiateromasica
IT1151779B (it) Composizioni farmaceutiche ad attivita' antineoplastica
IT1151780B (it) Composizioni farmaceutiche ad attivita' antineoplastica
IT1174759B (it) Composizione farmaceutica contenente salbutamol b-stimolante
FR2521008B1 (fr) Nouvelles compositions pharmaceutiques a base de thioridazine

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20030131